Autolus (AUTL) Chief Business Officer details ADS, options and RSU stakes
Rhea-AI Filing Summary
Autolus Therapeutics plc’s Chief Business Officer Christopher Michael James Williams filed an initial ownership report, detailing his equity interests in the company. He directly holds 19,808 American Depositary Shares and 8,198 ordinary shares.
He also holds multiple share options over American Depositary Shares with exercise prices ranging from $0.001 to $29.86 per share and expirations extending through 2036. In addition, he has 83,300 restricted share units, which the footnotes state will vest in four equal annual installments beginning on January 26, 2027, each representing the right to receive one American Depositary Share.
Positive
- None.
Negative
- None.
Insider Trade Summary
16 transactions reported
Mixed
16 txns
Insider
Williams Christopher Michael James
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Restricted Share Units | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 19,808 shares (Direct);
Share Option (right to buy) — 1,514,683 shares (Direct);
Restricted Share Units — 83,300 shares (Direct);
Ordinary Shares — 8,198 shares (Direct)
Footnotes (11)
- F1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one ordinary share.
- F2. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
- F3. Fully vested and exercisable.
- F4. This option vested 25% on July 22, 2023 and the remainder vests in 36 equal monthly installments thereafter.
- F5. This option vested 25% on March 6, 2024 and the remainder vests in 36 equal monthly installments thereafter.
- F6. This option vested 25% on October 12, 2024 and the remainder vests in 36 equal monthly installments thereafter.
- F7. This option vested 25% on February 23, 2025 and the remainder vests in 36 equal monthly installments thereafter.
- F8. This option vested 25% on March 14, 2026 and the remainder vests in 36 equal monthly installments thereafter.
- F9. This option vests 25% on January 26, 2027 and the remainder vests in 36 equal monthly installments thereafter.
- F10. The restricted share units ("RSUs") vest in four equal annual installments commencing on January 26, 2027.
- F11. Each RSU represents a contingent right to receive one Issuer American Depositary Share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Autolus (AUTL) disclose in Christopher Williams’s Form 3?
Autolus reported Chief Business Officer Christopher Michael James Williams’s initial equity holdings. The filing lists his direct American Depositary Shares, ordinary shares, multiple stock options over ADSs, and a large block of restricted share units with specified vesting schedules and expiration dates.
What stock options over Autolus (AUTL) ADSs does Christopher Williams report?
Williams reports several share options over American Depositary Shares with exercise prices from $0.001 to $29.86 per share. These options cover varying underlying ADS amounts and have expiration dates running from 2027 through 2036, illustrating a long-dated, option-based component of his compensation.